Earnings · China A-shares
R&G PharmaStudies Co., Ltd. Class A (301333) earnings
R&G PharmaStudies Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit -21.33% year on year, -18.75% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +3.46% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- -21.33%
- Excl. one-offs YoY
- -18.75%
- Net profit QoQ
- +41.97%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.93% | — |
| 3 days | +3.46% | — |
| 7 days | +9.32% | — |
| 14 days | +0.36% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +6.10%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥75.18M | -21.33% | -18.75% | +17.52% | 0.79 | 3.77% | +3.46% | — | — |
| 2026 interim report | 2026-08-28 | ¥44.46M | -27.25% | -19.60% | +23.26% | 0.46 | 2.23% | -2.82% | +1.81% | +11.50% |
| 2026 Q1 report | 2026-04-28 | ¥22.83M | -12.46% | -5.04% | +26.18% | 0.24 | 1.15% | -6.19% | -34.41% | -33.79% |
| 2025 annual report | 2026-03-28 | ¥136.90M | -2.37% | -1.47% | +14.38% | 1.43 | 7.21% | +15.29% | -5.52% | -14.88% |
| 2025 Q3 report | 2025-10-29 | ¥95.57M | +13.21% | +22.47% | +8.09% | 1.00 | 5.08% | +32.93% | +8.04% | +11.51% |
| 2025 interim report | 2025-08-28 | ¥61.12M | +4.45% | +9.52% | +0.18% | 0.64 | 3.28% | +5.94% | -0.25% | -5.75% |
| 2025 Q1 report | 2025-04-28 | ¥26.07M | +13.12% | +23.26% | -2.53% | 0.27 | 1.41% | +0.54% | +19.41% | +16.16% |
| 2024 annual report | 2025-03-28 | ¥140.22M | -13.73% | -11.36% | +3.14% | 1.47 | 7.86% | -0.38% | -14.15% | -13.06% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.